What America's Retirement Savings Gap Means for Pfizer Employees

A Retirement System That Has Shifted Responsibility

Over the past several decades, the structure of retirement in the United States has changed in a fundamental way. The defined benefit pension, which once covered roughly half of private-sector workers, now reaches only about 15 percent of the private-sector workforce. That shift moved the primary responsibility for retirement preparation off employers and onto individuals.

The problem is that most workers have not adjusted to that shift. Participation rates, savings rates, and average balances all point to a population that has not kept pace with what retirement now requires.

What the Numbers Show

Among private-sector workers, somewhere between 65 and 70 percent have access to an employer-sponsored retirement plan. Of those who have access, only about half actually participate. For workers in their 50s, the median 401(k) balance is roughly $85,000 to $95,000. For workers in their 60s, the median is similar.

Group	Median 401(k) Balance	Annual Income at 4% Withdrawal
Workers in their 50s	~$85,000-$95,000	~$3,400-$3,800/year
Workers in their 60s	~$88,000-$90,000	~$3,500-$3,600/year
Target for 30-year retirement	$750,000-$1,500,000+	$30,000-$60,000/year

Those are median figures, which means half the population has less. For most people, a balance in that range will not sustain a 20 or 30-year retirement, particularly once you account for healthcare costs and the compounding effects of inflation.

The downstream result is predictable: about 40 percent of current retirees depend on Social Security for more than half of their income. Between 15 and 20 percent depend on it for more than 90 percent of their income. Social Security was built to supplement retirement income, not replace it.

Where Pfizer Employees Stand Differently

Pfizer employees are generally in a better position than the national average. Most Pfizer companies offer competitive 401(k) plans with employer matching contributions, access to deferred compensation programs, stock purchase plans, and financial wellness resources that most private-sector workers never see.

But access does not automatically translate into adequate preparation. Some Pfizer employees do not contribute enough to capture the full employer match. Others have set a contribution rate and not revisited it as their income grew. Lifestyle inflation is real at every income level, and the assumption that there will be time to save more later shows up consistently in retirement planning conversations.

At The Retirement Group, what we see most often is not that Pfizer employees made dramatic mistakes. It is that small gaps, an under-optimized contribution rate, an unreviewed asset allocation, a Roth conversion decision that was never made, compounded quietly over years before anyone addressed them.

The Risk That Gets Overlooked

The national retirement data also points to a risk that does not get enough attention in good markets: sequence of returns. A market downturn in the first few years of retirement can permanently reduce a portfolio's ability to sustain withdrawals, even if the market eventually recovers fully.

For Pfizer employees accustomed to reliable income, the transition to portfolio-based withdrawals in retirement requires planning. A portfolio that looks sufficient in a strong market can look significantly different after an early-retirement correction.

This is why a withdrawal strategy needs to account for what happens in difficult conditions, not just what works in normal or favorable ones. At The Retirement Group, stress-testing a retirement income plan across a range of market scenarios is standard practice. The goal is a plan that holds together when conditions are difficult, not just when they are favorable.

Social Security and the Timing Decision

Even for Pfizer employees with strong savings, Social Security is a meaningful piece of retirement income. Higher lifetime earnings produce higher benefits, but the decision of when to claim still matters considerably.

Claiming early reduces the monthly benefit permanently. Waiting until age 70 increases it significantly. For a married couple, the coordination of two Social Security claims adds another layer of planning. The right answer depends on health, other income sources, tax situation, and how long retirement might reasonably last.

This is not a decision to make by default. For most Pfizer employees, Social Security claiming strategy is worth modeling carefully before making an irreversible choice.

What the National Picture Is Really Saying

The data on American retirement preparedness is not just a statistic about other people. It reflects what happens when individual savings behavior does not keep up with individual responsibility for retirement outcomes.

Pfizer employees have more advantages going into retirement than most Americans do. Better plan access, higher matching contributions, often higher incomes. The gap between those advantages and a funded retirement is not always large, but it can widen if the advantages are not used deliberately.

The families who navigate retirement most successfully tend to share one thing: they started planning in earnest before they needed to. They closed gaps when the gaps were still small. They worked with an advisor to coordinate tax strategy, income timing, and estate planning as a single integrated problem, not a series of disconnected decisions.

That kind of planning is available to Pfizer employees who choose to engage with it. The national retirement data is a useful reminder of why it matters.

Featured Video

Articles you may find interesting:

The national retirement data is not a picture of unavoidable outcomes. It reflects what happens when the shift from employer-funded to individually-funded retirement is not met with an equally serious shift in savings behavior. Pfizer employees have the resources and the access to do better. The ones who use those advantages deliberately tend to build retirement security that most Americans cannot match.

Most American workers face a critical retirement savings gap: insufficient assets to replace pre-retirement income. Pfizer helps close this gap through its employer retirement contributions. The company's defined benefit or cash balance pension provides guaranteed lifetime income at retirement, replacing a portion of pre-retirement salary without relying on investment performance or market conditions. This income floor is invaluable for stabilizing retirement—most American workers lack access to such protection. Combined with the 401(k) match (75% up to 6% of pay (4.5% effective company contribution)) represents a meaningful employer contribution, typically between 3% and 6% of salary annually. Over a 30-year career, this compounds significantly through tax-deferred growth.

Employees who maximize Pfizer's retirement benefits—contributing enough to capture the full match and, when possible, maximizing employer non-elective or profit-sharing contributions—can accumulate retirement balances well above the national average. A worker earning $75,000 annually who saves 10% (employee + employer) over 30 years could accumulate over $1 million in today's dollars, assuming 5% real returns. This illustrates the power of starting early and maintaining consistent contributions. However, savings gaps often result from low employee contributions, job changes that interrupt employer matching, or taking loans from the 401(k). Staying engaged with Pfizer's plan and maintaining contributions through job transitions maximizes the long-term value of the employer benefit.